The Valley Desk

NCT06021054 · Interventional trial

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

Overall registry status Completed

Phase 3

Conditions Thyroid Eye Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov